Efficacy and safety of treprostinil in pulmonary arterial hypertension: a meta-analysis of randomized trials
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disorder characterized by elevated pulmonary vascular resistance and mean pulmonary artery pressure. Treprostinil, a prostacyclin analog has vasodilatory and antiproliferative properties that may improve exercise capacity, hemodynamics an...